The goal of the OSU Advanced Research Training in Immunology for Surgery Trainees (ARTIST) program is to prepare surgical residents (postdoctoral trainees) for translational research careers involving study of how immune mechanisms affect tissue injury, repair, regeneration and replacement. This program is uniquely focused, serving a need that cannot currently be met at OSUWMC or perhaps anywhere else. As such, ARTIST will be a new paradigm for study and adoption by programs at other medical colleges. ARTIST integrates Immunology didactics, research-in-progress seminars and journal clubs from the College of Medicine Biomedical Sciences Graduate Program, as well as Translational Research courses from a novel """"""""Signature Program Translational Science Curriculum,"""""""" core courses in the Masters of Medical Science Program (Research Design, Grant Writing, Research Ethics, Biostatistics), and a new """"""""Career Development for Surgeons"""""""" course. In addition, networking opportunities and an annual program retreat will offer unique opportunities for career development. National leaders and department chairs in surgery, especially those who have first-hand experience as visiting professors, recognize the strengths of the OSU Department of Surgery's Residency and Research Training Program. A small cadre of our surgical trainees, all training grant eligible and highly diverse (~30% URM, 50% female), will be selected for ARTIST. We will also invite trainees from other academic institutions by competitive application. Trainees will dedicate two full-time years, without clinical responsibilities, towards research education and training, earning a Master's of Science in Medical Science degree. They will be prepared to apply their training to deepen understanding of the immune system, as well as developing new, immune-based diagnostics, prognostics, therapeutics and clinical approaches that are relevant to surgical procedures and outcomes. While in the program they will also learn how to develop and draw upon clinical databases that integrate surgical outcomes with data from pathology and immunology. ARTIST Faculty Trainers who lead or participate in NIH-funded Program Projects (P01) and Specialized Programs of Research Excellence (SPORE) will provide context for use of such valuable databases in cores for collaborative team science. Infrastructure for ARTIST will include relevant OSU institutional research centers, research cores, outstanding training faculty and departmental administration. ARTIST's NIH-funded faculty, with distinguished track records in immunology and translational research, have been specially selected to inspire and guide trainees in immunology-focused mentored research. Clinical co-mentors and a post-training longitudinal, career advisory committee will provide guidance and facilitate placement into prestigious fellowships and academic faculty positions for ARTIST trainees. The national impact of the ARTIST program will be realized through scientific maturation of a trainee group with comprehensive clinical expertise, with the ability to apply the power of immunology-based research to benefit surgical patients.

Public Health Relevance

The goal of this program is to train the next generation of surgeon-scientists who will lead immunity focused translational research programs. The results of this research will increase knowledge about immune system related surgical problems and/or lead to enhanced or new diagnostic, prognostic or therapeutic options for surgical patients. This training program is distinguished by an outstanding, collaborative and interactive group of surgical trainees and faculty, an immunology focused didactic curriculum leading to a Master's of Science in Medical Science degree, and an emphasis on formalized longitudinal career development and leadership training for future academic surgeons in an interdisciplinary and collaborative research environment and top quality medical center.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Allergy & Clinical Immunology-1 (AITC)
Program Officer
Prograis, Lawrence J
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Ohio State University
Schools of Medicine
United States
Zip Code
Best, Cameron A; Pepper, Victoria K; Ohst, Devan et al. (2018) Designing a tissue-engineered tracheal scaffold for preclinical evaluation. Int J Pediatr Otorhinolaryngol 104:155-160
Onwuka, Ekene; King, Nakesha; Heuer, Eric et al. (2018) The Heart and Great Vessels. Cold Spring Harb Perspect Med 8:
Beal, Eliza W; Dumond, Curtis; Kim, Jung-Lye et al. (2018) A Small Animal Model of Ex Vivo Normothermic Liver Perfusion. J Vis Exp :
Al-Mansour, Mazen R; Fung, Eleanor C; Jones, Edward L et al. (2018) Surgeon-performed endoscopic retrograde cholangiopancreatography. Outcomes of 2392 procedures at two tertiary care centers. Surg Endosc 32:2871-2876
Mace, Thomas A; Shakya, Reena; Pitarresi, Jason R et al. (2018) IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer. Gut 67:320-332
Lo, Wilson D; Evans, David C; Yoo, Taehwan (2018) Computed Tomography-Measured Psoas Density Predicts Outcomes After Enterocutaneous Fistula Repair. JPEN J Parenter Enteral Nutr 42:176-185
Onwuka, Ekene; Best, Cameron; Sawyer, Andrew et al. (2017) The role of myeloid cell-derived PDGF-B in neotissue formation in a tissue-engineered vascular graft. Regen Med 12:249-261
Yoo, Taehwan; Starr, Jean E; Go, Michael R et al. (2017) Ultrasound-Guided Thrombin Injection Is a Safe and Effective Treatment for Femoral Artery Pseudoaneurysm in the Morbidly Obese. Vasc Endovascular Surg 51:368-372
Beal, Eliza W; Black, Sylvester M; Michaels, Anthony (2017) Autoimmune Hepatitis in the Liver Transplant Graft. Clin Liver Dis 21:381-401
Spolverato, Gaya; Bagante, Fabio; Ethun, Cecilia G et al. (2017) Defining the Chance of Statistical Cure Among Patients with Extrahepatic Biliary Tract Cancer. World J Surg 41:224-231

Showing the most recent 10 out of 42 publications